Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Biotalys receives EPA approval for bio-fungicide Evoca and shares rise
The US Environmental Protection Agency (EPA) has approved Biotalys's first bio-fungicide, Evoca, completing the regulatory review process. After the approval, Biotalys can submit registration applications in California and Florida, the main US growing regions for fruits and vegetables. Evoca targets fungal diseases such as Botrytis and powdery mildew; the company is also developing a more efficiently manufactured successor version (Evoca NG) with expected US approval in 2028/2029 and EU/Brazil approval in 2029/2030. » More on de.investing.com
Biotalys shares rise after positive EPA vote for Evoca
Biotalys shares gained about 14% after the US Environmental Protection Agency (EPA) issued a proposed approval for the protein-based biofungicide Evoca. The EPA is thus initiating the final phase of the review process; stakeholders can comment within 15 days before the final decision is made. Evoca is seen as an important test for Biotalys’ business model; the company has production and distribution agreements with Novonesis and AgroFresh. Analysts at Kepler view the vote as a clear breakthrough for the investment case, also ahead of a possible EU approval. » More on de.investing.com
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 0 | 100.00% |
| Gross profit | 0 | 100.00% |
| Net profit | -4.57M | 12.39% |
| EBITDA | -3.33M | 8.33% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €106.79M |
Number of shares | 45.44M |
52-week high/low | €5.28 - €1.56 |
| Dividends | No |
Beta | 1.37 |
P/E ratio | -5.34 |
PEG ratio | 0.77 |
P/B ratio | 6.17 |
P/S ratio | 0.00 |
Company profile
Biotalys NV, ein Agrartechnologieunternehmen, erforscht und entwickelt neuartige biologische Produkte für den Schutz von Lebensmitteln und Nutzpflanzen. Das Unternehmen entwickelt hauptsächlich Biofungizide, Bioinsektizide und Biobakterizide. Das Unternehmen war früher unter dem Namen Agrosavfe NV bekannt. Biotalys NV wurde im Jahr 2013 gegründet und hat seinen Hauptsitz in Gent, Belgien.
| Name | Biotalys NV Actions au Porteur o.N. |
| CEO | Carlo Boutton |
| Headquarters | Gent,
Belgium |
| Website | |
| IPO | 07/02/2021 |
| Employees | 38 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Euronext | BTLS.BR |
Brussels Stock Exchange | BTLS.BR |
Frankfurt | 86C.F |
Düsseldorf | 86C.DU |
München | 86C.MU |
Discover assets
Shareholders of Biotalys NV Actions au Porteur o.N. also invest in the following assets
